Bayer today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for expanded capabilities of ...
DENVER--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced the U.S. commercial availability of Covidien Imaging Solutions’ contrast ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market Report for Contrast Agents and Injectors 2016 - MedCore" report to their offering. The U.S. market for ...
The use of automated contrast injector systems during percutaneous coronary intervention (PCI) does not appear to curb kidney damage compared with manual injection, according to an analysis published ...
As per the DBMR Team predictions cited in Contrast Injector Market report, the market will grow with a specific CAGR value in the forecast period of 2021 to 2028. The First Class Contrast Injector ...